Literature DB >> 2025824

Apolipoproteins and risk of coronary heart disease.

P W Connelly1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2025824      PMCID： PMC1335182     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  Is it time to measure apolipoprotein B?

Authors:  A D Sniderman; J Silberberg
Journal:  Arteriosclerosis       Date:  1990 Sep-Oct

2.  Does measurement of apolipoprotein B have a place in cholesterol management?

Authors:  G L Vega; S M Grundy
Journal:  Arteriosclerosis       Date:  1990 Sep-Oct

3.  Standardization of commercial assays for serum Apo A-I and Apo B: a consensus procedure for the calibration of reference materials.

Authors:  F Dati
Journal:  Scand J Clin Lab Invest Suppl       Date:  1990

4.  Essential data derived from biological variation for establishment and use of lipid analyses.

Authors:  R P Ford
Journal:  Ann Clin Biochem       Date:  1989-05       Impact factor: 2.057

5.  Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B.

Authors:  G Brown; J J Albers; L D Fisher; S M Schaefer; J T Lin; C Kaplan; X Q Zhao; B D Bisson; V F Fitzpatrick; H T Dodge
Journal:  N Engl J Med       Date:  1990-11-08       Impact factor: 91.245
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.